Virological confirmation of suspected dengue in a Phase 2 Latin American vaccine trial: Implications for vaccine efficacy evaluation Fulltext Access 7 Pages 2014
Influence of maternally-derived antibodies in 6-week old dogs for the efficacy of a new vaccine to protect dogs against virulent challenge with canine distemper virus, adenovirus or parvovirus Fulltext Access 7 Pages 2014
Novel neutralizing monoclonal antibodies protect rodents against lethal filovirus challenges Fulltext Access 6 Pages 2014
Humoral and lung immune responses to Mycobacterium tuberculosis infection in a primate model of protection Fulltext Access 5 Pages 2014
Prophylactic antibody treatment and intramuscular immunization reduce infectious human rhinovirus 16 load in the lower respiratory tract of challenged cotton rats Fulltext Access 9 Pages 2014
Protective immune mechanisms against pre-erythrocytic forms of Plasmodium berghei depend on the target antigen Fulltext Access 5 Pages 2014
Non-specific immunity of BCG vaccine: A perspective of BCG immunotherapy Fulltext Access 7 Pages 2014
DNA vaccination for rabies: Evaluation of preclinical safety and toxicology Fulltext Access 8 Pages 2014
Randomized trial: The effect of oral polio vaccine at birth on polio antibody titers at 6 weeks and 6 months of age Fulltext Access 7 Pages 2014
The feasibility of rabies virus-vectored immunocontraception in a mouse model Fulltext Access 8 Pages 2014
Neonatal BCG vaccination is associated with enhanced T-helper 1 immune responses to heterologous infant vaccines Fulltext Access 5 Pages 2014
Highly immunogenic prime–boost DNA vaccination protects chickens against challenge with homologous and heterologous H5N1 virus Fulltext Access 7 Pages 2014
Chimeric avian paramyxovirus-based vector immunization against highly pathogenic avian influenza followed by conventional Newcastle disease vaccination eliminates lack of protection from virulent ND virus Fulltext Access 8 Pages 2014
A novel dual promoter DNA vaccine induces CD8+ response against Toxoplasma gondii sporozoite specific surface protein “SporoSAG” through non-apoptotic cells Fulltext Access 8 Pages 2014
Co-administration of an adjuvanted FeLV vaccine together with a multivalent feline vaccine to cats is protective against virulent challenge with feline leukaemia virus, calicivirus, herpes virus and panleukopenia virus Fulltext Access 7 Pages 2014
Bupivacaine enhances the magnitude and longevity of HIV-specific immune response after immunization with a CD4 epitope-based DNA vaccine Fulltext Access 7 Pages 2014
The administration of a single dose of a multivalent (DHPPiL4R) vaccine prevents clinical signs and mortality following virulent challenge with canine distemper virus, canine adenovirus or canine parvovirus Fulltext Access 5 Pages 2014
HIV-1 Gag-specific exosome-targeted T cell-based vaccine stimulates effector CTL responses leading to therapeutic and long-term immunity against Gag/HLA-A2-expressing B16 melanoma in transgenic HLA-A2 mice Fulltext Access 7 Pages 2014
A Phase III, randomized study to evaluate the immunogenicity and safety of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in HIV-positive adults Fulltext Access 7 Pages 2014
Antibody persistence to meningococcal serogroups A, C, W and Y in toddlers two years after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate (MenACWY-TT) vaccine as measured by bactericidal antibody assays using rabbit or human c Fulltext Access 6 Pages 2014
Long-peptide therapeutic vaccination against CRPV-induced papillomas in HLA-A2.1 transgenic rabbits Fulltext Access 9 Pages 2014
An integrated multi-study analysis of serum HAI antibody responses to Ann Arbor strain live attenuated influenza vaccine in children and adults Fulltext Access 4 Pages 2014